Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | Supply Chain Coordination Limited |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £960,000,000 |
| Release Date: | 3 December 2025 |
| Application Deadline: | 10 March 2025 |
| Contract Start Date: | 28 November 2025 |
| Contract End Date: | 27 November 2027 |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-b5fd17-13650ef2-0040-42d4-98e9-af1283571b69 |
| Notice Reference: | e2997ca2-77d7-4e3e-80ae-017b0d61b828-874606 |
All 4 notices for this procurement, oldest first.
Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products
Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products
Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products
Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products
Earlier notices predate the Procurement Act 2023 (commenced 24 Feb 2025) and therefore don't carry UK1–UK17 codes.
View Original Notice
Access the full notice on the official portal
Awarded to (12 suppliers)
| Award value: | £1,067,000,000 |
| Award decision date: | 5 November 2025 |
| Award status: | Active |
NHS Supply Chain seeks to establish a Framework Agreement for the supply of Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products. This includes but not limited to tethered and patch insulin pumps, continuous glucose monitoring devices, products that contribute to the functionality of hybrid closed loop insulin delivery systems, and consumables. Precise quantities are unknown. It is anticipated in the first year that spend will be approximately £ 240,000,000 - £267,000,000 GBP (Excluding VAT), however this is approximate only and may vary depending on requirements of bodies purchasing under the Framework. Estimated total value over the 4 year agreement is approximately £960,000,000 to £1,067,000,000 Excluding VAT. Please note it is expected that the yearly spend for years 2 , 3 and 4 of the Framework Agreement will rise significantly. Following the National Institute for Health and Care Excellence (NICE) Technology Appraisal TA943 Overview | Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes | Guidance | NICE published 19th December 2023 and the NHS England Implementation Plan https://www.england.nhs.uk/long-read/hybrid-closed-loop-technologies-5-yearimplementationstrategy/
Published contracts in the last 12 months
46
total contracts
£4447.6m
total value
£234,083,995
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
10 March 2025
Closed
Estimated Value
£960,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →